Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion

被引:70
作者
Helgeson, Melvin D. [1 ]
Lehman, Ronald A., Jr.
Patzkowski, Jeanne C. [3 ]
Dmitriev, Anton E. [2 ]
Rosner, Michael K. [4 ]
Mack, Andrew W. [1 ]
机构
[1] Walter Reed Army Med Ctr, Integrated Dept Orthopaed & Rehabil, Washington, DC 20307 USA
[2] Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Spine Res Lab, Washington, DC 20307 USA
[3] Brooke Army Med Ctr, Dept Orthopaed Surg, San Antonio, TX 78234 USA
[4] Walter Reed Army Med Ctr, Dept Surg, Neurosurg Serv, Washington, DC 20307 USA
关键词
Osteolysis; Resorption; Transforaminal lumbar interbody fusion; Bone morphogenetic protein; RHBMP-2; ALLOGRAFT; RESORPTION; OUTCOMES;
D O I
10.1016/j.spinee.2011.01.017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND CONTEXT: Recent studies have demonstrated cases of adjacent vertebral body osteolysis when assessing the effect of bone morphogenetic protein (BMP) on fusion rates. However, no study to date has evaluated the course of osteolysis at different periods. PURPOSE: To determine the incidence and resolution of osteolysis associated with BMP used in transforaminal lumbar interbody fusions (TLIF). STUDY DESIGN: Retrospective review. PATIENT SAMPLE: All TLIF cases using BMP performed at one institution with routine postoperative computed tomography (CT) scans at defined intervals. OUTCOME MEASURES: Area of osteolysis and fusion as determined by CT scan. METHODS: We performed a retrospective analysis of all patients at our facility who underwent TLIF with BMP. Included were all patients who had obtained a CT scan within 48 hours of surgery, 3 to 6 months postoperatively, and 1 to 2 years postoperatively. Areas of osteolysis were defined as lucency within the vertebral body communicating with the interbody spacer that was not present on the immediately postoperative CT scan. Areas of osteolysis were measured in all three planes and the volume used for comparison of the 3 to 6 months CT scans with the greater than 1 year CT scan. RESULTS: Twenty-three patients who underwent TLIF with BMP had obtained CT scans at all time periods required for evaluation. Seventy-eight vertebral bodies/end plates were assessed for osteolysis (39 levels). The incidence of osteolysis 3 to 6 months postoperatively in the adjacent vertebral bodies was 54% compared with 41% at 1 to 2 years. The mean volume of osteolysis was at 0.216 cm(3) at 1 to 2 years compared with 0.306 cm(3) at 3 to 6 months (p-.082). The area/rate of osteolysis did not appear to significantly affect the rate of fusion or final outcome with an overall union rate of 83%. CONCLUSIONS: The rate of osteolysis decreased at 1 year compared with 3 to 6 months, but only 24% of the vertebral bodies with evidence of osteolysis at 3 to 6 months completely resolved by 1 year. Published by Elsevier Inc.
引用
收藏
页码:507 / 510
页数:4
相关论文
共 10 条
[1]   Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft [J].
Burkus, JK ;
Sandhu, HS ;
Gornet, MF .
SPINE, 2006, 31 (07) :775-781
[2]   Transforaminal lumbar interbody fusion: A retrospective study of Long-term pain relief and fusion outcomes [J].
Chastain, Cody A. ;
Eck, Jason C. ;
Hodges, Scott D. ;
Humphreys, S. Craig ;
Levi, Peggy .
ORTHOPEDICS, 2007, 30 (05) :389-392
[3]   Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: A report of five cases [J].
Lewandrowski, Kai-Uwe ;
Nanson, Christopher ;
Calderon, Robert .
SPINE JOURNAL, 2007, 7 (05) :609-614
[4]   Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2) [J].
McClellan, John W. ;
Mulconrey, Daniel S. ;
Forbes, Robert J. ;
Fullmer, Nancy .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2006, 19 (07) :483-486
[5]   Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report - Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004 [J].
Mummaneni, PV ;
Pan, J ;
Haid, RW ;
Rodts, GE .
JOURNAL OF NEUROSURGERY-SPINE, 2004, 1 (01) :19-23
[6]   Transforaminal lumbar interbody fusion - Clinical and radiographic results and complications in 100 consecutive patients [J].
Potter, BK ;
Freedman, BA ;
Verwiebe, EG ;
Hall, JM ;
Polly, DW ;
Kuklo, TR .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2005, 18 (04) :337-346
[7]  
Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01
[8]   Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes [J].
Slosar, Paul J. ;
Josey, Robert ;
Reynolds, James .
SPINE JOURNAL, 2007, 7 (03) :301-307
[9]   Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence [J].
Vaidya, R. ;
Weir, R. ;
Sethi, A. ;
Meisterling, S. ;
Hakeos, W. ;
Wybo, C. D. .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2007, 89B (03) :342-345
[10]   Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2 [J].
Villavicencio, AT ;
Burneikiene, S ;
Nelson, EL ;
Bulsara, KR ;
Favors, M ;
Thramann, J .
JOURNAL OF NEUROSURGERY-SPINE, 2005, 3 (06) :436-443